BackAmplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Overview

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Receivables

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's receivables is $1.5B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.52B
↑ 1151.11% YoYΔ $1.40B vs prior year quarter

Peer trimmed avg / median

Loading

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Receivables History

Loading

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF vs. peers: Receivables Comparison

Loading

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF (GERM) FAQ

As of the most recent data (June 2026), GERM shows a receivables of $1.5B. That compares with $120M in the prior-year period — up 1151.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GERM's receivables is now $1.5B (was $120M) — a 1151.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF is outperforming or lagging.

Tracking GERM's receivables over time shows whether Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5B That compares with $120M in the prior-year period — up 1151.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.5B) with ownership activity and broader fundamentals.